Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Dec;18(6):895–899. doi: 10.1111/j.1365-2125.1984.tb02561.x

Drug metabolism in diabetic subjects with fatty livers.

H I Pirttiaho, P I Salmela, E A Sotaniemi, R O Pelkonen, U Pitkänen, P V Luoma
PMCID: PMC1463685  PMID: 6529530

Abstract

The effect of fatty degeneration of liver parenchyma on drug metabolism was investigated in 21 obese non-insulin-dependent diabetic subjects by measuring plasma antipyrine kinetics, hepatic cytochrome P-450, liver size and the extent of fatty infiltration. The hepatic drug metabolising capacity, as measured by total antipyrine clearance and the estimated total amount of cytochrome P-450, was at the same level as in non-diabetic control subjects with normal livers. Relative antipyrine clearance (per unit weight of liver) and cytochrome P-450 concentrations were significantly lower in the diabetics than in controls. The extent of fatty infiltration correlated poorly with the indices of drug metabolism. In non-insulin-dependent diabetics, slight to moderate hepatic fatty infiltration, without more serious structural distortion interfering with hepatic blood flow or hepatocellular function, seems to have only a minor influence on drug metabolism.

Full text

PDF
895

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arranto A. J., Sotaniemi E. A. Morphologic alterations in patients with alpha-methyldopa-induced liver damage after short- and long-term exposure. Scand J Gastroenterol. 1981;16(7):853–863. doi: 10.3109/00365528109181814. [DOI] [PubMed] [Google Scholar]
  2. Branch R. A. Drugs as indicators of hepatic function. Hepatology. 1982 Jan-Feb;2(1):97–105. doi: 10.1002/hep.1840020115. [DOI] [PubMed] [Google Scholar]
  3. Branch R. A., Shand D. G. Propranolol disposition in chronic liver disease: a physiological approach. Clin Pharmacokinet. 1976;1(4):264–279. doi: 10.2165/00003088-197601040-00002. [DOI] [PubMed] [Google Scholar]
  4. Greim H., Schenkman J. B., Klotzbücher M., Remmer H. The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the rat. Biochim Biophys Acta. 1970 Jan 27;201(1):20–25. doi: 10.1016/0304-4165(70)90005-x. [DOI] [PubMed] [Google Scholar]
  5. Hepner G. W., Vesell E. S., Lipton A., Harvey H. A., Wilkinson G. R., Schenker S. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination. J Lab Clin Med. 1977 Sep;90(3):440–456. [PubMed] [Google Scholar]
  6. Homeida M., Roberts C. J., Halliwell M., Read A. E., Branch R. A. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease. Gut. 1979 Jul;20(7):596–601. doi: 10.1136/gut.20.7.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kadar D., Inaba T., Endrenyi L., Johnson G. E., Kalow W. Comparative drug elimination capacity in man-glutethimide, amobarbital, antipyrine, and sulfinpyrazone. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):552–560. doi: 10.1002/cpt1973144part1552. [DOI] [PubMed] [Google Scholar]
  8. Pirttiaho H. I., Pitkänen U. Size and blood flow of the liver estimated by 99Tcm scanning. Acta Radiol Ther Phys Biol. 1977 Dec;16(6):497–506. doi: 10.3109/02841867709133971. [DOI] [PubMed] [Google Scholar]
  9. Prescott L. F., Adjepon-Yamoah K. K., Roberts E. Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol. 1973 Mar;25(3):205–207. doi: 10.1111/j.2042-7158.1973.tb10625.x. [DOI] [PubMed] [Google Scholar]
  10. Rollo F. D., DeLand F. H. The determination of liver mass from radionuclide images. Radiology. 1968 Dec;91(6):1191–1194. doi: 10.1148/91.6.1191. [DOI] [PubMed] [Google Scholar]
  11. Salmela P. I., Sotaniemi E. A., Pelkonen R. O. The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus. Diabetes. 1980 Oct;29(10):788–794. doi: 10.2337/diacare.20.10.788. [DOI] [PubMed] [Google Scholar]
  12. Sotaniemi E. A., Ahlqvist J., Pelkonen R. O., Pirttiaho H., Luoma P. V. Histological changes in the liver and indices of drug metabolism in alcoholics. Eur J Clin Pharmacol. 1977 Apr 20;11(4):295–303. doi: 10.1007/BF00607680. [DOI] [PubMed] [Google Scholar]
  13. Thaler H. Relation of steatosis to cirrhosis. Clin Gastroenterol. 1975 May;4(2):273–280. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES